- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Pfizer Ratings Report.
The company has spent $600 million weighing a potential breakup.
Bernstein analysts say Pfizer (PFE) is likely to continue seeking M&As following the end of its planned business split.
Stocks are lower Monday as Wall Street's attention shifts to the looming presidential debate from central bank policy.